Barclays PLC lifted its holdings in shares of Regulus Therapeutics Inc. (NASDAQ:RGLS – Free Report) by 285.2% during the 3rd quarter, Holdings Channel reports.The firm owned 84,477 shares of the ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback